To include your compound in the COVID-19 Resource Center, submit it here.

Forest Laboratories generics, pharmaceuticals news

Forest issued a statement in response to an SEC filling from activist investor Carl Icahn questioning whether Forest's board

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE